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Abstract
Heptakis{6-deoxy-6-[12-(thiododecyl) undecanamido-b-cyclodextrin has been produced by reaction of Heptakis(6-
deoxy-6-amino)-b-cyclodextrin and 12-(thiododecyl)undecanoic acid using O-Benzotriazol-1-yl-N,N,N¢,N¢-tetram-
ethyluronium tetraﬂuoroborate (TBTU) as activating agent. Self-assembled monolayers of this macrocycle have
been used in a surface plasmon resonance (SPR) sensor; it has been shown that this system is suitable to discriminate
between D and L enantiomers of thyroxine, with a greater afﬁnity for the D-enantiomer.
Introduction
Molecular recognition [1–3] is one of the most impor-
tant concepts in biological/biochemical sciences. It
implies a set of weak forces (non-covalent) interactions
ranging from hydrogen–bonds to van der Waals
interactions through ionic and dipole–dipole interac-
tions [4]. In biological systems, because of the asym-
metry of a large majority of molecules (proteins,
carbohydrates, nucleic acids, etc.) these interactions
occur in an asymmetric fashion. Keeping this in mind,
it seems obvious that artiﬁcial drugs have to be chiral
to be integrated correctly in the vast and complex game
of molecular interactions of living systems [5]. In fact, it
has been demonstrated that in many cases, while they
behave similarly in a symmetric environment, two
enantiomers of the same molecule have different effects
in biological systems [6]. Thus, it is of great importance
to develop, in parallel to asymmetric synthetic meth-
odologies, separation and sensing systems able to
discriminate between two optical isomers. In the past
few decades, many chiral selectors have been designed
for chiral separation by high performance liquid
chromatography (HPLC) [7], gas chromatography
(GC) [8] and capillary electrophoresis (CE) [9] and
are used in the pharmaceutical industry for enantio-
analysis. In contrast, enantiospeciﬁc sensing systems are
much less well developed. Nevertheless, there are some
reports on the use of quartz crystal microbalance
(QCM) [10–14] and surface plasmon resonance (SPR)
[15, 16] based sensors for enantio-analysis of mixtures.
For example, it has been shown that imprinted polymer
ﬁlms could be efﬁcient QCM functional layers for
enantioselective detection of serine [10], terpenes [11],
dansyl-phenylalanine [12] and propanolol [13]. Paolese
et al. [14] have shown that a self assembled monolayer
(SAM) of a porphyrin diad on a QCM electrode is able
to enantio-discriminate analytes in the gas-phase. Films
prepared by the spreader-bar approach have also been
used as sensitive layers in a SPR sensor in order to
discriminate between diﬀerent binaphthyl diols [15].
a, b and c-Cyclodextrins are macrocyclic molecules
composed of 6, 7 or 8 D-glucopyranose units respec-
tively, linked by a-(1ﬁ4) glycosidic bonds [17]. They
have been widely studied in supramolecular/host-guest
chemistry [1–3] due to their ability to include lipophilic
molecules in their hydrophobic cavity. They have also
been extensively used as chiral selectors in separation
technology [18] and it has been shown that cyclodextrin
based polymers could be used as sensitive layers in chiral
sensing by SPR [16]. Reinhoudt has extensively studied
the ability of these macrocycle to form well packed
SAMs on gold surfaces [19–24].
L-Thyroxine (3,3¢,5,5¢-tetraiodothyronine or T4) is a
derivative of tyrosine (Figure 1), it is the major hormone
secreted by thyroid follicular cells [25] and is used as a
biochemical indicator of thyroid function. Synthetically
prepared thyroxine is used in the treatment of thyroid
gland deﬁciency diseases.
In this paper, we report on enantioselective sensing
of thyroxine by SPR using as a sensitive functional
layer a SAM of Heptakis{6-deoxy-6-[12-(thiododecyl)
undecanamido]}-b-cyclodextrin (3) produced via an* Author for correspondence. E-mail: Patrick.Shahgaldian@unibas.ch
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improved synthetic approach (Figure 2) compared to
that described in literature [24].
Experimental
Synthesis
General
13C and 1H NMR spectra were recorded on a Varian
300 MHz.Electro-SprayMassSpectrometry (ES-MS)was
performed using a Perkin Elmer Sciex API 165 in positive
mode. Solvents (ACS grade for synthesis andHPLC grade
for ES-MS) and chemicals were purchased from Fluka
(Switzerland) and used without further puriﬁcation.
Heptakis(6-deoxy-6-amino)-b-cyclodextrin, 1 [26],
and 12-(thiododecyl)undecanoic acid, 2 [27], have been
synthesized according to literature procedures.
Synthesis of Heptakis{6-deoxy-6-[12-(thiododecyl)unde-
canamido]}-b-cyclodextrin (3)
Under anhydrous condition, in dry DMF, at 0 C, 2
(625 mg, 1.56 mmol), O-Benzotriazol-1-yl-N,N,N¢,N¢-
tetramethyluronium tetraﬂuoroborate (TBTU)
(495 mg, 1.56 mmol) and 4-ethylmorpholine (400 ll,
3.02 mmol) were dissolved and maintained under stir-
ring during 10 min. After the addition of 1 (250 mg,
0.22 mmol) the mixture was allowed to warm at room
temperature and stirred for additional 16 h. All DMF
was evaporated under reduced pressure and the yellow
residue obtained dissolved in dichloromethane (100 ml),
washed with HCl (1 M, 100 ml), water (100 ml), dried
over magnesium sulphate and evaporated. The pale
yellow residue produced was dissolved in dichlorme-
thane (5 ml), the addition of acetone (100 ml) yielded a
white solid, which was ﬁltered and copiously washed
with acetone to aﬀord 3 (505 mg) in 60% yield. All
analytical values (TLC, ES-MS, 1H and 13C NMR) are
in perfect agreement with those published [24].
Sensor chip preparation and SAM formation
All glassware used to prepare monolayers was cleaned in
piran˜a solution (H2SO4:H2O2; 70:30, v/v) and abun-
dantly rinsed with de-ionized water (puriﬁed with a
Millipore MiliQ water system, resistivity ‡ 18 MW cm)
(Warning: piran˜a solution is highly oxidative and corro-
sive; it could explode unexpectedly and must be handled
with extreme care). SIA Kit Au (glass substrates
(10 · 12 mm) covered on one side with a 50 nm thick
gold layer) obtained from BIAcore (Uppsala, Sweden)
were cleaned as follows. Gold substrates were immersed
in acetone and submitted to ultrasonic treatment during
20 min. This treatment was repeated with methanol.
They were subsequently immersed in a piran˜a solution
during 1 h, washed abundantly with de-ionized water,
acetone and dried under argon. Self-assembled mono-
layers of 3 were prepared by immersing freshly cleaned
gold substrates in a 0.1 M solution of 3 (EtOH:CHCl3,
1:2, v/v) during 16 h. Subsequently, the substrates were
removed from the solution, thoroughly rinsed with
chloroform, dried and assembled in the chip holder.
Surface plasmon resonance (SPR) experiments
Binding assays were performed using a BIAcore X
apparatus. Sensor chips were equilibrated using a
BIAcore HBS-N buﬀer (0.01 M HEPES pH 7.4,
0.15 M NaCl, ﬁltered and degassed) using the contin-
uous ﬂow procedure overnight (5 ll min)1). Thyroxine
solutions were prepared as follows: D- or L- thyroxine
(7.7 mg) were dissolved in 1 ml NaOH 1 N solution and
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Figure 1. Molecular formula of thyroxine (3,3¢,5,5¢-tetraiodothyro-
nine).
Figure 2. Synthesis of Heptakis{6-deoxy-6-[12-(thiododecyl)undecanamido]}-b-cyclodextrin, TBTU: O-Benzotriazol-1-yl-N,N,N¢,N¢-tetrameth-
yluronium tetraﬂuoroborate and NEM: N-ethylmorpholine.
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then diluted in the running buffer (1/100). Mixtures of
enantiomers were prepared by mixing these solutions
and degassed prior to use. Experiments were carried out
using a ﬂow rate of 5 ll/min and 35 ll of thyroxine
solution for each binding assay.
The BIAevaluation software was utilized for eval-
uation of binding constants using the 1:1 Langmuir
adsorption model. The model given by the manufacturer
for a 1:1 binding experiment is explained by the
following equations:
d½B
dt
¼ ðka  ½A  ½B  kd  ½AB
d½AB
dt
¼ ðka  ½A  ½B  kd  ½AB
Ka ¼ kakd
where ka is the association rate constant, kd the
dissociation rate constant, Ka the association constant,
[A] the concentration of the analyte, [B] the concentra-
tion of the ligand, [AB] the concentration of the complex
formed by binding A to B. Values for d[AB]/dt and
d[B]/dt are obtained from measurements of the slope at
multiple time points during the real-time binding–
unbinding experiment.
Regeneration of the sensor chip was achieved by
competitive elution (injection of 35 ll of a 0.1 M
b-cyclodextrin solution in NaOH (0.1 M) and ﬂushed
with the running buﬀer until the value measured came
back to the baseline). Each experiment was repeated at
least twice to ensure reproducibility of the results.
Results and discussion
Synthesis
The synthetic route to heptakis{6-deoxy-6-[12-(thiodo-
decyl)undecanamido-b-cyclodextrin, 3, is presented in
Figure 2. It has been carried out by reacting Heptakis(6-
deoxy-6-amino)-b-cyclodextrin (1) and 12-(thiodecyl)
undecanoic (2) using O-Benzotriazol-1-yl-N,N,N¢,N¢ -
tetramethyluronium tetraﬂuoroborate (TBTU) as acti-
vating agent in freshly dried dichloromethane. This
reaction aﬀords 3 in 60% yield. The synthesis of 3 has
been previously described by Beulen et al. [24]. In this
paper, the authors report on the use of N,N¢ -dic-
yclohexylcarbodiimide (DCC)/1-hydroxybenzotriazol
(HoBT) as coupling agents. This synthetic procedure
requires extra puriﬁcation of the crude product twice by
ﬂash chromatography and results in a loss of material
(yield: 45%). In the procedure proposed here, all reagents:
2, TBTU and its degradation product (HoBT) are soluble
in acetone and no column puriﬁcation is necessary, the
yield of the reaction is therefore improved.
Thyroxine binding assays
In Figure 3 are presented binding sensograms measured
for D- and L-thyroxine. After the equilibration stage,
during all the experiment (including binding–unbinding
and regeneration steps) a stable baseline was obtained
(not shown) suggesting that no degradation of the SAM
occurs. During the short initial phase of the injection of
analytes, a clear uptake is observed for both senso-
grams, this initial increase could be mainly attributed to
the change of refractive index in the measurement cell
due to the change of buffer. After this initial variation,
the sensor response measured for the L-enantiomer
shows a slight increase up to 400 arbitrary unit (au)
while those for the D-enantiomer is much more higher,
almost linear and reach a 37% higher value, at the end
of the injection, of 550 au. During the unbinding
(washing) step, the sensor response for the L-enantiomer
decreases rapidly and asymptotically approaches the
baseline while the value for D-enantiomer decreases
more slowly and levels off at a value of 220 au. From
this, we conclude that there is a differential selective
binding of the D over L-enantiomers of thyroxine on a
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Figure 3. Binding sensograms of D- and L-thyroxine, values are expressed in arbitrary units and normalized to 0 at the beginning of the injection.
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sensor chip where a chiral SAM of 3 is immobilized and
exposed as a sensor layer.
The afﬁnity constant (Kaﬀ) for the D-enantiomer
(4.7 · 108 M)1) is much more important than those
for L-enantiomer (3.8 · 105 M)1). As evocated in the
introduction, cyclodextrins have been widely used for
chiral separation of small molecules; this ability to
enantio-discriminate analytes arises from a diﬀerential
inclusion of guest molecules in the chiral cavity of the
cyclodextrins. We can expect that chiral sensing prop-
erties of cyclodextrin based SAMs measured in the
presented experiments are due to the same inclusion
phenomenon. A schematic representation of a possible
inclusion complex between thyroxine and the cyclodex-
trin skeleton is presented in Figure 4. It could be
supposed that the interaction occurs by a deep inclusion
of the hydrophobic part of thyroxine (D or L- enanti-
omers) in the lipophilic cavity of the cyclodextrin
skeleton. Thus, the chiral center and the polar functions
of thyroxine are segregated outside the macrocycle and
interact, in an enantioselective fashion, with secondary
alcohol functions of the cyclodextrin molecule through
hydrogen bonding.
The ability of 3-based SAMs to discriminate between
the two enantiomers of thyroxine has been evaluated by
monitoring the apparent aﬃnity constant with varying
proportions of each enantiomer, these results are pre-
sented in Figure 5. There is a linear increase of the
apparent aﬃnity constant ranging from the value
measured for the L-enantiomer to that measured for
the D-enantiomer. It means that this sensor could be
used for the evaluation of the enantiomeric composition
of a mixture of D- and L-thyroxine. It must be noted
that problems of reproducibility should arise from
differences in the quality of the gold layers which cause
variations in the surface coverage of the SAM. Never-
theless this problem could be circumvented by measur-
ing for each chip a ‘calibration curve’ as done in
Figure 4.
Conclusion
In this paper, a new synthetic route to heptakis{6-deoxy-
6-[12-(thiododecyl)undecanamido-b-cyclodextrin using
O-Benzotriazol-1-yl-N,N,N¢,N¢-tetramethyluronium tet-
raﬂuoroborate is described. SAMs of these cyclodextrins
have been prepared and used in a SPR sensor. It has
been shown that these chiral SAMs possess enantiose-
lective binding properties and present a greater aﬃnity
for the D-enantiomer of thyroxine with regard to the L-
enantiomer. In view of the widespread use of cyclodext-
rins and principally b-cyclodextrin in chiral separation,
it seems obvious that the use of 3-based SAMs as
sensitive layers for chiral sensors could be expanded to a
large range of analytes. Actually, the main limitation for
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Figure 4. Schematic representation of the inclusion complex of thy-
roxine in the cyclodextrin cavity.
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Figure 5. apparent aﬃnity constants measured for varying proportions of D- and L-thyroxine.
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the design of a highly versatile chiral sensor using SPR
detection system is the limitation of the technique to
water soluble molecules with relative high molecular
weight (typically higher than 500). Investigations are
currently underway to transfer 3-based SAMs on more
sensitive systems (microcantilever arrays) in order to
expand the number of analytes which could be analyzed.
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